Corteva, Inc. $CTVA Shares Sold by Aristotle Capital Management LLC

Aristotle Capital Management LLC decreased its holdings in Corteva, Inc. (NYSE:CTVA) by 6.5% in the 1st quarter, HoldingsChannel reports. The firm owned 18,833,712 shares of the company’s stock after selling 1,311,336 shares during the quarter. Corteva makes up 3.3% of Aristotle Capital Management LLC’s portfolio, making the stock its 3rd largest holding. Aristotle Capital Management LLC’s holdings in Corteva were worth $1,576,574,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. JPL Wealth Management LLC bought a new position in Corteva in the 3rd quarter valued at about $25,000. Garton & Associates Financial Advisors LLC bought a new stake in shares of Corteva during the 4th quarter worth about $27,000. Bank of Jackson Hole Trust acquired a new stake in shares of Corteva in the 4th quarter worth approximately $28,000. Cornerstone Financial Management LLC acquired a new stake in shares of Corteva in the 4th quarter worth approximately $29,000. Finally, Basepoint Wealth LLC bought a new position in shares of Corteva in the fourth quarter valued at approximately $30,000. 81.54% of the stock is currently owned by institutional investors.

Corteva News Summary

Here are the key news stories impacting Corteva this week:

• Positive Sentiment: Oppenheimer raised its price target on Corteva to $95 from $89 and kept an “outperform” rating, signaling confidence in further upside for the stock.
• Positive Sentiment: Zacks upgraded Corteva to Rank #2 (Buy), citing improving earnings prospects ahead of the company’s upcoming results.
• Positive Sentiment: Analysts expect Q2 earnings growth as premium seed demand, new products, and productivity gains help offset pricing and inflation pressure. Corteva Set to Report Q2 Earnings: What Investors Should Expect
• Neutral Sentiment: Corteva declared a quarterly dividend of $0.18 per share, payable September 15 to shareholders of record on September 1, which supports the stock’s income profile but is not a major growth catalyst. Corteva Declares Quarterly Dividend
• Neutral Sentiment: The company is set to report Q2 earnings soon, and investors are awaiting confirmation that demand and operating efficiency trends are holding up. Corteva (CTVA) Projected to Release Quarterly Earnings on Thursday

Corteva Price Performance

Shares of CTVA opened at $89.23 on Friday. The business’s 50-day moving average is $81.39 and its 200-day moving average is $78.91. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.47 and a quick ratio of 1.03. The company has a market capitalization of $59.68 billion, a price-to-earnings ratio of 52.49, a P/E/G ratio of 2.69 and a beta of 0.56. Corteva, Inc. has a fifty-two week low of $60.53 and a fifty-two week high of $89.39.

Corteva (NYSE:CTVA) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, beating analysts’ consensus estimates of $1.18 by $0.32. The firm had revenue of $4.91 billion for the quarter, compared to the consensus estimate of $4.64 billion. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The firm’s revenue was up 11.0% on a year-over-year basis. During the same period in the previous year, the firm posted $1.13 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Equities research analysts expect that Corteva, Inc. will post 3.76 EPS for the current fiscal year.

Corteva Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st will be paid a $0.18 dividend. The ex-dividend date of this dividend is Tuesday, September 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.8%. Corteva’s dividend payout ratio is 42.35%.

Analysts Set New Price Targets

Several equities research analysts recently commented on CTVA shares. Bank of America boosted their target price on Corteva from $90.00 to $96.00 and gave the stock a “buy” rating in a report on Monday, July 20th. Mizuho lifted their price target on Corteva from $96.00 to $97.00 and gave the company an “outperform” rating in a research report on Tuesday, July 14th. Barclays upped their price objective on Corteva from $84.00 to $91.00 and gave the company an “overweight” rating in a report on Thursday, June 11th. Morgan Stanley raised their target price on Corteva from $84.00 to $95.00 and gave the company an “overweight” rating in a research note on Thursday, May 28th. Finally, UBS Group lowered their target price on Corteva from $90.00 to $86.00 and set a “neutral” rating on the stock in a report on Tuesday, June 9th. One analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and eight have issued a Hold rating to the company. According to data from MarketBeat.com, Corteva currently has an average rating of “Moderate Buy” and an average price target of $90.19.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.